Similarly, in renal cell and liver cancers, high expression of H2AX is an unfavourable prognostic marker (source: proteinatlas.org); advanced stage (I versus II–IV), H2AX high expressing breast tumours also showed significantly worse OS (p = 0.007) and DFS (p = 0.001). Here, H2AX is linked to breast neoplasm.